Expert Interview

This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

Discussing novel therapies for influenza and associated exposure-response analysis.

Ticker(s): CDTX, VIR

Who's the expert?

Institution: Icahn School of Medicine at Mount Sinai

Professor in the Department of Microbiology and Director of the Global Health and Emerging Pathogens Institute of Icahn School of Medicine at Mount Sinai.
Research interest includes the molecular biology of influenza viruses.
Has authored over 480 scientific publications and reviews.

Interview Goal

This call will focus on long-acting influenza PrEP agents with emphasis on Cidara's CD388, historic landscape (VIR's VIR-2482) and other neuraminidase (NA) inhibitors

Are You Interested In These Questions?

Yes! Sign me up for FREE
so I can learn more Yes.
LOGIN!

Click Here to Access
This Project

Slingshot Insights Explained

JOIN FOR FREE TODAY

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

Click Here to Access
This Project

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.